Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
Hu L, Napoletano A, Provenzano M, Garofalo C, Bini C, Comai G, La Manna G.
Int J Mol Sci. 2022 Oct 13;23(20):12223. doi: 10.3390/ijms232012223.
Hypercalcemia: A Review.
Walker MD, Shane E.
JAMA. 2022 Oct 25;328(16):1624-1636. doi: 10.1001/jama.2022.18331.
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z.
J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20.
Cancer-related hypercalcemia and potential treatments.
Almuradova E, Cicin I.
Front Endocrinol (Lausanne). 2023 Mar 22;14:1039490. doi: 10.3389/fendo.2023.1039490. eCollection 2023.
Osteoporosis: A Review.
Morin SN, Leslie WD, Schousboe JT.
JAMA. 2025 Sep 9;334(10):894-907. doi: 10.1001/jama.2025.6003.
Osteoporosis: Clinical Evaluation.
Lewiecki EM.
2024 Nov 2. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Use of bisphosphonates in chronic kidney disease is associated with cardiovascular death.
Borghoff KA, Ounda AE, Swee ML, Girotra S, Shibli-Rahhal AA, Ten Eyck P, Jalal DI, Jovanovich AJ.
Clin Nephrol. 2025 Jan;103(1):5-11. doi: 10.5414/CN111428.
Vascular calcification: Molecular mechanisms and therapeutic interventions.
Pan W, Jie W, Huang H.
MedComm (2020). 2023 Jan 3;4(1):e200. doi: 10.1002/mco2.200. eCollection 2023 Feb.
Drug-induced nephrotoxicity.
Sales GTM, Foresto RD.
Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s82-s90. doi: 10.1590/1806-9282.66.S1.82.
Bisphosphonates and management of kidney stones and bone disease.
Prochaska M.
Curr Opin Nephrol Hypertens. 2021 Mar 1;30(2):184-189. doi: 10.1097/MNH.0000000000000682.
